WLD-D24-003 · Observed 2025-04-26
emergingSynthetic-biological Incident
Qualitative signpost review · no probability assigned
Bounded observation
NIH requirements effective 26 April 2025 require NIH-funded procurement of synthetic nucleic acids and benchtop synthesis equipment to use providers or manufacturers following sequence and customer screening practices. This operationalises a control point prompted by misuse risk, but the notice reports no verified screening bypass or unusual biological cluster.
Trigger threshold
Move to observed only on a verified screening bypass, audit failure linked to acquisition, or unusual cluster with authoritative evidence of synthetic origin.
Counter-indicator
The policy is a preventive procurement control within NIH-funded work and is evidence of mitigation capacity, not evidence that a synthetic-biological incident occurred.
Update criterion
Review compliance audits, reported illegitimate orders and the revised federal screening framework; downgrade if screening coverage becomes comprehensive and no bypass evidence emerges.